n-(4-isothiocyanatophenethyl)spiperone has been researched along with butaclamol in 1 studies
Studies (n-(4-isothiocyanatophenethyl)spiperone) | Trials (n-(4-isothiocyanatophenethyl)spiperone) | Recent Studies (post-2010) (n-(4-isothiocyanatophenethyl)spiperone) | Studies (butaclamol) | Trials (butaclamol) | Recent Studies (post-2010) (butaclamol) |
---|---|---|---|---|---|
7 | 0 | 1 | 233 | 3 | 2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ferré, S; Finnman, UB; Fuxe, K; Owman, C; Rinken, A; Terasmaa, A | 1 |
1 other study(ies) available for n-(4-isothiocyanatophenethyl)spiperone and butaclamol
Article | Year |
---|---|
Modulation of [(35)S]GTPgammaS binding to chinese hamster ovary cell membranes by D(2(short)) dopamine receptors.
Topics: Animals; Binding, Competitive; Butaclamol; CHO Cells; Cricetinae; Dopamine; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Guanosine 5'-O-(3-Thiotriphosphate); Guanosine Diphosphate; Membranes; Raclopride; Radioligand Assay; Rats; Receptors, Dopamine D2; Spiperone; Sulfur Radioisotopes; Tritium | 2000 |